Live Webinar

Secondary Care Webinar 3 – Off-beat patients: Treating atrial fibrillation and other arrhythmias in patients with hypertrophic cardiomyopathy (First schedule)

Course Overview

This event will take place twice on June 29th, 2023
First schedule: 1pm EDT / 7pm CEST
Second schedule: 7pm EDT / 1am CEST (+1)

This expert webinar is designed to improve knowledge around the management of arrhythmias in patients with hypertrophic cardiomyopathy (HCM). It assists secondary healthcare professionals to:

  • better understand the pathophysiology of atrial fibrillation (AFib) and arrhythmias in HCM patients
  • determine the best management strategy for symptomatic AFib patients

This webinar is 60 minutes duration.

Target audience

Cardiologists, echocardiographers, electrophysiologists, cardiac sonographers, cardiology nurses, nurse practitioners, registered nurses, physician assistants, pediatricians, pediatric nurses.

Funding disclosure

This activity is supported by educational grant funding from Bristol Myers Squibb and Cytokinetics. Learners may participate in this educational activity free of charge.


  • Welcome and overview of arrhythmias and HCM
  • Pharmacologic management of atrial fibrillation
  • Pharmacologic management of ventricular arrhythmias
  • Non-pharmacologic management of atrial fibrillation
  • Non-pharmacologic management of ventricular arrhythmias
  • Q&A and closing remarks​

By the end of this activity, attendees will be able to:

  • outline the risk of developing atrial fibrillation and other arrhythmias in patients with HCM
  • summarize the consequences of atrial fibrillation and other arrhythmias on patients with HCM
  • describe appropriate pharmacological management strategies for patients with atrial fibrillation and HCM
  • describe appropriate non-pharmacological management strategies for patients with atrial fibrillation and HCM

This activity will provide continuing education (CE) credits for physicians, physician assistants, nurses and nurse practitioners.

Professor T. Jared Bunch, MD, University of Utah Health, US, has received past research grants from Boehringer Ingelheim, AltaThera Pharmaceuticals, and Boston Scientific.

AffinityCE staff, PCM Scientific staff, as well as planners and reviewers have no relevant financial interests to disclose.

Mitigation of relevant financial relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.